ILMN
Illumina Inc
$181.10
4.55 (2.58%) Today
— up— down
Market Cap
$26.71B+91.1%
Revenue (TTM)
$4.32B+1.3%
Net Income (TTM)
$835.77M
$835.77MEPS (TTM)
5.52
5.52Shares Out
151.30M
151.30MP/E Ratio
31.32
31.32Forward P/E
29.65
29.65Open
$177.39
$177.39Previous Close
$176.55
$176.55Day Range
$175.13 – $181.28
$175.13 – $181.2852-Week Range
$88.00 – $182.84
$88.00 – $182.84Beta
1.42
1.42Volume
1.39M
1.39MAvg Volume
1.78M
1.78MExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ILMN
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Related
News
Comcast's NBCUniversal spinoff raises hope for more deals. There may not be good options
CNBC · 1h ago
Wall Street indexes rise as US, Iran attacks ease; major tech-related shares jump - Reuters
Reuters · 1h ago
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
CNBC · 1h ago
Chip stocks rebound, and Goldman racks up a series of M&A wins
CNBC · 1h ago
Here's how Trump Accounts could affect women's retirement savings gap
CNBC · 2h ago